This inventor holds 2 USPTO granted patents and 5 published patent applications and 4 EPO patents. Top assignees: Sekisui Medical Co., Ltd., Social Welfare Organization Saiseikai Imperial Gift Foundation, Inc., Other. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2025
Title: Jiro Hirota: Innovator in Immunoassay Methods
Introduction
Jiro Hirota is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of immunoassay methods, particularly in the detection of specific biomarkers in biological samples. With a total of 2 patents, Hirota's work focuses on improving diagnostic techniques that are crucial for patient care.
Latest Patents
Hirota's latest patents include an "Immunoassay method for free AIM in biological sample" and a "method for detecting NASH in subject." The first patent addresses the need to enhance the specificity for free AIM of an antibody that specifically reacts with free AIM. This method aims to diagnose NASH without imposing a burden on patients and medical staff. The solution involves an immunoassay method that brings the biological sample into contact with an antibody specifically reacting with free AIM in the presence of an anti-IgM antibody. The second patent also focuses on improving the specificity of an anti-AIM antibody for free AIM in a biological sample containing complex AIM and free AIM.
Career Highlights
Throughout his career, Jiro Hirota has worked with Sekisui Medical Co., Ltd., where he has contributed to advancements in medical diagnostics. His expertise in immunoassay methods has positioned him as a key figure in the field.
Collaborations
Hirota has collaborated with notable colleagues such as Toru Miyazaki and Takeshi Okanoue. These partnerships have further enriched his research and development efforts.
Conclusion
Jiro Hirota's innovative work in immunoassay methods has the potential to significantly impact medical diagnostics. His patents reflect a commitment to improving patient care through advanced technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile